Want to see FR:ALRPD full AI Analyst Report?
ALRPD Stock Chart & Stats
€4.00
-€0.10(-2.50%)
At close: 4:00 PM EDT
€4.00
-€0.10(-2.50%)
Day’s Range― - ―
52-Week Range€3.26 - €15.00
Previous CloseN/A
Volume7.17K
Average Volume (3M)8.33M
Market Cap
€24.19M
Enterprise Value-€2.60M
Total Cash (Recent Filing)€8.55M
Total Debt (Recent Filing)€77.87K
Price to Earnings (P/E)―
Beta-0.40
Next Earnings
Sep 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.37
Shares Outstanding6,219,934
10 Day Avg. Volume19,904,828
30 Day Avg. Volume8,334,412
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.17
Price to Sales (P/S)7.55
P/FCF Ratio-0.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)€2.21M
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageExtremely low reported leverage (debt-to-equity ~0.01) materially reduces short-term insolvency risk and interest burden. This durable capital-structure strength improves flexibility to execute restructuring or raise growth capital on more favorable terms while operations stabilize.
Positive Gross MarginA roughly 27% gross margin shows the company's core products have positive unit economics. That structural margin provides a foundation for recovery: with fixed-cost reductions or volume restoration, the business can more readily return to operating profitability than peers lacking unit-level contribution.
Improving Free Cash Flow TrendAn improvement in free cash flow versus the prior year indicates early traction in cost control or revenue stabilization. While still negative, a durable improvement trend lowers immediate financing pressure and supports a path toward self-funding if continued over coming quarters.
Bears Say
Sharp Revenue ContractionA ~72% year-over-year revenue collapse is a structural concern: loss of demand, contract exits, or commercialization failure sharply reduces scale and pricing leverage. Such a decline impairs fixed-cost absorption and makes sustainable margin recovery and investment much harder over the medium term.
Deep Persistent LossesAn extreme net loss (net margin near -1,596%) indicates severe value erosion and likely structural profitability issues or large non-recurring write‑downs. Persistent deep losses undermine equity, limit reinvestment in R&D/commercialization, and weaken competitive positioning in a capital‑intensive drug market.
Continued Cash BurnSustained negative operating and free cash flow (~-€3.1M) forces reliance on external financing and raises dilution and execution risk. Over multiple quarters this persistent cash burn can constrain operations, slow product development, and increase probability of capital‑raising under unfavorable terms.
Rapid Nutrition News
ALRPD FAQ
What was Rapid Nutrition PLC’s price range in the past 12 months?
Rapid Nutrition PLC lowest stock price was €3.26 and its highest was €15.00 in the past 12 months.
What is Rapid Nutrition PLC’s market cap?
Rapid Nutrition PLC’s market cap is €24.19M.
When is Rapid Nutrition PLC’s upcoming earnings report date?
Rapid Nutrition PLC’s upcoming earnings report date is Sep 29, 2026 which is in 47 days.
How were Rapid Nutrition PLC’s earnings last quarter?
Rapid Nutrition PLC released its earnings results on May 19, 2026. The company reported -€1.714 earnings per share for the quarter, missing the consensus estimate of N/A by -€1.714.
Is Rapid Nutrition PLC overvalued?
According to Wall Street analysts Rapid Nutrition PLC’s price is currently Overvalued.
Does Rapid Nutrition PLC pay dividends?
Rapid Nutrition PLC does not currently pay dividends.
What is Rapid Nutrition PLC’s EPS estimate?
Rapid Nutrition PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rapid Nutrition PLC have?
Rapid Nutrition PLC has 6,219,934 shares outstanding.
What happened to Rapid Nutrition PLC’s price movement after its last earnings report?
Rapid Nutrition PLC reported an EPS of -€1.714 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.304%.
Which hedge fund is a major shareholder of Rapid Nutrition PLC?
Currently, no hedge funds are holding shares in FR:ALRPD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rapid Nutrition PLC
Rapid Nutrition PLC is a natural healthcare enterprise that researches, develops, and manufactures a diverse portfolio of science-backed health and wellness products. Its market presence extends across the United Kingdom, Australia, Asia, the United States, and other international regions. The company offers a range of organic and natural, scientifically formulated health food supplements, primarily distributed under the SystemLS and Leisa's Secret trademarks. Furthermore, it produces oral antiviral therapeutic solutions, marketed as Azurene, aimed at combating influenza and the common cold. The company was established in 2001 and is headquartered in London, UK.